Literature DB >> 377474

Deposits of immunoglobulins and complement in skin of patients with rheumatoid arthritis. Influence of anti-rheumatic treatment.

S Ullman, M Høier-Madsen, P Halberg, H Jans, J Sylvest.   

Abstract

Immunopathological studies on skin biopsies from 88 patients with rheumatoid arthritis showed that one-third of them had deposits of IgM and/or C3 in the walls of small vessels immediately underneath the dermal-epidermal junction. The deposits in the vessel walls which may reflect subclinical immune complex vasculitis could be correlated to the occurrence of IgG-rheumatoid factor in the serum, but not to IgM-rheumatoid factor, other extra-articular manifestations, or to the occurrence of circulating immune complexes demonstrated by the complement consumption test or the thrombocyte aggregation test. Two untreated patients had granular deposits in the dermal-epidermal junction. Five out of 50 patients developed deposits in the dermal-epidermal junction during treatment with levamisole, penicillamine, or azathioprine, as observed by serial skin biopsies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377474     DOI: 10.3109/03009747909105349

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  6 in total

1.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

2.  Rheumatoid factor false positivity in patients with ANCA-associated vasculitis not having medical conditions producing rheumatoid factor.

Authors:  Jae-Seung Moon; Diane Da-Hyun Lee; Yong-Beom Park; Sang-Won Lee
Journal:  Clin Rheumatol       Date:  2017-11-08       Impact factor: 2.980

3.  Immunological comparison of patients with rheumatoid arthritis with and without nephropathy.

Authors:  M Korpela; J Mustonen; H Helin; A Pasternack
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

4.  IgE deposition in normal skin of patients with rheumatoid arthritis in relation to clinical and laboratory findings.

Authors:  L S De Clerck; M L Westedt; A Cats; B J Vermeer; E F Weltevreden; C H Bridts; W J Stevens
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

5.  A three-year prospective study of systemic manifestation in rheumatoid arthritis.

Authors:  H Mielke; W Daniel; H Deicher; W Drommer; M Fischer; R Fritsch; H Müller-Vahl; G W Sybrecht
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

6.  Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: a platelet specific immunoglobulin inducing the release reaction.

Authors:  E Weissbarth; B Baruth; H Mielke; W Liman; H Deicher
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.